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ABSTRACT

“RITALIN AND THE CHILD”

Valerie Vickers

This study focuses on Attention Deficit Hyperactivity Disorder (ADHD) the
history of the disease, sufferers, individual accounts from sufferers, and both positive
outcomes and negative repercussions of its treatment. Extensive secondary research and
the collection of a personal account form the body of the work. The information focuses
attention on key points regarding the historical background of ADHD, including: the
discovery of the disease, change in categories of drugs used to control it, and the rate of
evolution in thoughts on and treatment of the disease. Also researched are the various
guidelines as well as ignored factors in the diagnosing of ADHD, in addition to
information dealing with alternative therapies. A significant portion of this thesis
involves discussing ADHD as it relates to the family, and society. Causal factors such as
divorce and the effect parents, educators, and the media have on treatment strategies are
addressed.

DEDICATION

The author wishes to dedicate this text to a generation of children, who by no fault
of their own have been lost in the shuffle of life, as we all now know it.
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CHAPTER I
FOCUS ON THE MATERIAL
Problem Statement
In the past 20 years a very interesting sociological change has taken place.
Societies have become faster and extremely complex environments for living. With the
ever-growing number of divorces, single parent homes, and foster care family situations,
our children are suffering the consequences. Even in conditions where there are two
parents present, kids seem to be on their own as both adults often work.
One of the very disturbing trends accompanying this change is the increase in the
number of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD).
This behavioral diagnosis is a fairly new way of applying a label to children with deviant
behaviors. Along with this diagnosis, comes the widespread practice of medicating these
children in an attempt to deter their bad behavior. By putting this diagnosis into a
medical category, parents find it easier to allow their children to be drugged, with little
knowledge of any long-term effects the medication might have for them. This trend is
becoming more and more acceptable in families of the late 20th and early 21st centuries
and is alarming simply because no long-term studies exist to determine if the procedures
used to diagnose, the guidelines for medication, and follow-up treatments are appropriate
to the problem, or even under what context the problem exists.

Purpose of Study
Behavior modification and management drugs are a fairly new sector of treatment
for the population and one of the few, which treats conditions that may have no outwardly
observable or quantifiable cause. It would seem that behavior modification drugs are an
area of treatment ripe for miscalculation, misconduct, and misuse on many levels.
The purpose of this study is to determine the history of and influences on behavior
modification drugs and the theories that surround their usage, as that said usage pertains to
a particular class of drugs Ritalin and Ritalin type medications, and a particular set of
users children at or below school-age who have been diagnosed with Attention Deficit
Hyperactivity Disorder (ADHD) or similar conditions. This study further attempts to view
1

ADHD within its historical context and to define ADHD and associated conditions,
discover the boundaries of its diagnosis, assess the viability of alternative treatments, assess
the viability of current medications and the sociological effects of the disease that
contribute to its presence and diagnosis. Also this study looks at the way government, the
North American public and pharmaceutical companies interact to bring about the climate,
which encourages the diagnosis of ADHD and opts for medical alternatives to traditional
behavioral modification techniques and therapies.

Introduction
My interest in the ever-growing phenomenon of Attention Deficit Hyperactivity
disorder (ADHD) began several years ago with my own nineteen-year-old nephew. At
the time of his diagnosis, parents were just accepting the help they were offered, even if it
meant treatment with amphetamines like Ritalin.
My nephew was adopted at birth, and from the beginning he had birth defects, and
developmental delays. His father is a board certified Pediatrician, and at the time of his
birth his mother was a neonatal nurse at a local hospital. They both understood the
problems they might face in the future; however, nothing could have prepared them for
the behavioral problems that their son would exhibit very early in life. By the age of
three he was defiant and not easily persuaded to follow directions. By pre-school he was
unable to follow even the simplest directions and just refused to stay on task.
By the time he entered elementary school he had become more and more
frustrated with the expectations placed on him. His academic standing was never above
average and with each passing year he fell further and further behind the other children.
When his parents sought professional help they were immediately offered the options of
medication and behavioral management regimens. At this point any help was welcome.
His school was a public institution at that time and offered special help for students with
learning disabilities.
For a while the prescribed medicine was Ritalin and my nephew seemed to
become more manageable at school. His grades were passing, and it wasn’t such a
2

struggle to get him to do his homework. Overtime, new and improved medications were
available and each time he changed to a new medication certain behaviors resulted.
Sadness and depression soon became major side effects for my nephew. He
didn’t really have friends other than his sisters and a close cousin. Weight gain was also
a major problem. His mother could not make the decision if the side effects were worse
than the problem itself. My nephew made the decision himself. He stopped taking all the
drugs that had for so long controlled his life. At that time he was enrolled in a private
school with no extra help or programs for behaviorally or educationally challenged
children. His parents hired tutors and his new friends helped him to keep his academic
standing within passing range. Without the drugs he was happier and more mobile. He
made friends and seemed to enjoy his life more. His academic life continued to be a
difficult struggle; however, his life was expanding in other ways.
His parents had to accept that he was not going to be an above average student,
and with that understanding they had to put themselves in a mindset that would allow
them to set their own goal and direct his attention towards high school graduation, even if
that goal and his focus on it seemed impossible to maintain.
My nephew at nineteen continues to have conduct and defiance problems,
problems that will no doubt follow him through adulthood. Despite these obstacles he
has finally made friends of his own, maintains a level of energy throughout the day, and
feels a general sense of well-being, which is a state he did not find himself in for many
years.
Years later my younger brother and his wife had a son. When this nephew was
two years of age his parents divorced. Not long after this divorce this nephew became
more and more easily agitated and increasingly difficult to handle. By the time he
entered pre-school his behavior was termed “out of control”. He was seen as the class
bully because of his tendency to act out in class and his learning was put in jeopardy by
his inability to stay on task.
Halfway into the first grade his teachers were at the point of expelling him from
school entirely. They insisted my brother seek help for him. As they requested, my
3

brother did seek help and was immediately offered Ritalin-type medications to take care
of or treat these problems.
My brother flatly refused to put his son on medication. The school system agreed
to follow an individual education plan (IEP) that would assist his son in areas where he
needed help, like reading. This nephew is in second grade now, and while some days are
harder than others and his behavior is not consistent, he is able to function in the
classroom without any medication. In both cases it is a struggle that my siblings, and the
whole family must face together. In both cases we have chosen to face the problem of
ADHD without drug therapy.
No one knows what the long-term prognosis of ADHD is, and studies related to
long-term use of Ritalin-type drugs only show fourteen-month outcomes. This leaves
parents with nowhere to turn and nothing to rely on except their own instincts and what
little information is available if they want to make an informed decision about their
child’s drug therapy. In the fall of 1999 I accepted an RN position at a local psychiatric
facility. I worked on a unit that treated children up to age eleven for behavioral and
psychiatric disorders.
While working on this unit I became increasingly uncomfortable with the
practices and standards used to govern the administering of narcotics to children, some of
them as young as three years old. I watched, and yes even participated in, what I
eventually felt was the making of drug addicts out of children.
Granted, the treatment plans of these children also contained behavioral
modification that might put parents minds at ease, but in my experience when behaviors
didn’t change fast enough, medications were changed and/or the dosages were increased.
These children would often experience insomnia and a drug would be added to combat
this side effect. If they showed signs of depression, further drugs were prescribed and if
undue weight gain resulted there were yet more prescriptions for that.
I am not saying that all of these children were diagnosed poorly or wrongly
medicated. I am saying that other treatment modalities may have worked. Many of these
children lived in home environments that were not conducive to good behavior. I felt that
we were masking superficial problems whose roots were deeper and more complex than
4

might successfully be addressed by the drugs offered or the limited time children stay in
such facilities.
After working for nearly two years in this hospital, I could not find justification for
continuing these practices, which made me uncomfortable. I have since done extensive and
much needed research on the subject, and feel a sense of resolve about what I feel is right
for the correct long-term treatment of children and drug therapy for behavior control.

Limitations and Assumptions
This study focuses on only a circumspect amount of the data available for research
on ADHD and Ritalin and Ritalin-type drug uses. This study does not assess the presence
of preexisting psychological conditions, heredity of ADHD, or other preexisting
psychological and/or physiological conditions working in tandem with ADHD. The focus
of this study limits itself to the historical background of ADHD and its associated drugs,
the medical diagnosis of ADHD and associated problems with this diagnosis, and the
interplay between this disease and the greater society through public advertisement and
pressures external to those instigated by the family of the child diagnosed with ADHD.
This study does not assess the sociological ramifications of ADHD on adults with the
diagnosis, or the specific issues related to ADHD and ethnicity or gender.
This study is also limited by secondhand accounts from available research sources
and does not depend on independent research projects, beyond one interview conducted
with an individual concerning his haven taken Ritalin in a school environment, for its
primary information. Several of the assumptions of this study have been substantiated
through first-hand experience on the part of the researcher dependent upon the researcher’s
background as a registered nurse with particular experience in the psychiatric care and
medication of troubled juveniles. This study limits itself to the opinion and conclusions
garnered from this experience, and does not attempt to associate these opinions and
conclusions with any specific patient or specific experience that the researcher encountered
while working as a psychiatric nurse. This limitation is self-imposed as any specific data
used in this study would have been gathered from an underage individual without the
5

consent of a parent, guardian, or court-appointed official and would thereby be invalid and
a violation of these individual’s rights.
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CHAPTER II

HISTORICAL BACKGROUND
Discovery of ADHD
The brief history of the development of ADHD and the practice of drug therapy
for the behavior modification of children began with the practice of drugging delinquent
boys with amphetamines. It began in the mid-1930’s with a physician in Providence, RI.
Dr. Charles Bradley decided to study what caused delinquent behavior in adolescent
boys. In his study he happened upon a way to calm the boys bad behavior through drugs.
He found that giving these boys stimulants like amphetamines actually aided in
increasing their ability to remain attentive and focus in school. Thus the first generation
of drugs to treat hyperactivity was born (Park, 63). During this time the primary focus of
medication for behavior modification therapy was to quiet the delinquent or antisocial
behavior of young men. Early recommendations for the use of medication therapy were
limited to boys who were considered beyond the help offered by regulated environments
(i.e. reformatories, orphanages, or other public programs for children). In the early
history of amphetamine use to medicate behavior disorder, there was no clinical
diagnosis such as ADHD and the problem was one considered isolated to “bad”
adolescent males from unstable or unfavorable family environments. In short, the
behavior being modified was not considered to be malformed by some quantifiable or
biological cause but rather by a combination of lack of parenting and a possible
inheritable characteristic towards delinquency. This diagnosis was not applied often to
females though one wonders why it was not, and it was certainly not applied to many
children outside the public systems, which care for and recommend medication for
children without familial supervision.
This early attempt to modify behavior with amphetamines was quickly replaced
by ever-increasing and evolving drugs, which are now part of a drug cocktail commonly
prescribed to children who have been diagnosed with ADHD. What is the future like for
these children? What prospects can they have for healthy minds, bodies, and families?
How will long-term amphetamine use affect the growing bodies of a substantial portion
7

of the American population? How do families cope with Ritalin and other drugs, where
else can they turn, and what should they know about all these new drugs? These remain
in large part unanswered questions.

Rate of Evolution in Drugs for the Treatment of ADHD
The treatment of ADHD, once achieved with the administration of amphetamines,
has evolved into the dispensation of an entire class of drugs. Stimulants, antidepressants
and blood-pressure drugs are all now used to treat ADHD. Stimulants include: Ritalin
(methylphenidate), Metadate ER and Concerta (longer-acting types of methylphenidate,
Dexedrine and DextroStat (dextroamphetamine or d-amphetamine), Adderall (damphetamine and amphetamine mixture), Desoxyn (methamphetamine), Gradumet (longacting form of methamphetamine), and Cyclert (pemoline) (Breggin, Talking Back to
Ritalin, Appendix A). These drugs all work in primarily the same way by increasing brain
function in key areas of organization and concentration by saturating the nerve cells with
chemicals like nor epinephrine, serotonin, and dopamine. Twenty percent of those who
are prescribed amphetamines do not respond to them correctly or respond to them in
some maladaptive way. Many of these individuals are prescribed an even older class of
drugs for behavior modification called trycyclic amines, or antidepressants. These drugs
primarily function to maintain or increase levels of serotonin or nor epinephrine in the
brain but may show no appreciable effect on the symptoms of ADHD. What has been
somewhat effective in the treatment of ADHD is a class of drugs called alpha-adrenergic
agents. These drugs function to maintain or increase levels of nor epinephrine in the
brain and were originally used to treat high blood pressure. These drugs have also proved
effective in reducing the presence of other disorders in patients like excessive anxiety and
impulse control issues common to individuals diagnosed with ADHD. These drugs are
not the only drug therapies available. A comprehensive table listing medications used to
treat ADHD and common dosages for these drugs follows in the following section.
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Categories of Drugs Used to Treat ADHD

Table 1 Common Medications Used to Treat ADHD:

Usual
initial dose

Single-dose
range

Dosage range

Dosage schedule

Tablet: 5, 10
and 20 mg

0.3 to 0.6
mg per kg
per dose, or
2.5 to 5 mg

0.3 to 0.8
mg per kg

5 to 80 mg
per day

Two or three times
daily: full dose given 30
minutes before breakfast
and lunch; half-dose
given at 3:00 to 4:00
p.m.

Ritalin-SR

Tablet: 20 mg

20 mg

0.6 to 2 mg
per kg, or
20 to 40 mg

20 to 80 mg
per day

Once or twice daily

Concerta

Tablet: 18
and 36 mg

18 mg

18 mg

18 to 54 mg
per day

Once daily

Generic, Dexedrine

Capsule: 5,
10 and 15 mg

0.15 mg per
kg, or 2.5 to
5 mg

0.15 to 0.5
mg per kg

5 to 40 mg

Two or three times daily

Dexedrine
Spansules

Capsule: 5,
10 and 15 mg

5 mg each
morning

0.3 to 0.8
mg per kg,
or 5 to 20
mg

5 to 40 mg
per day

Once or twice daily

Amphetaminedextroamphetamine
(Adderall)

Tablet: 5, 10,
20 and 30 mg

2.5 to 5 mg

0.15 to 0.5
mg

2.5 to 40 mg
per day

Once or twice daily

Pemoline (Cyclert)

Tablet: 18.75,
37.5 and 75
mg
Chewable
tablet: 37.5
mg

18.75 mg
each
morning

0.5 to 2.5
mg per kg

2 mg per kg,
or 18.75 to
112.5 mg per
day

Once or twice daily

Medication

How
supplied

Methylphenidate,
immediate release
Generic,
Ritalin,
Methylin
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Table 2 Symptoms Associated with Drugs Prescribed for ADHD
Methylphenidate,
immediate release
Generic, Ritalin,
Methylin

Average:
1.9 hours;
range: 0.3
to 4 hours

20 to 60
minutes

3 to 6
hours

Contraindications: motor tics, glaucoma,
history of seizures, hypertension, pregnancy
Recommended monitoring: height, weight,
blood pressure, pulse Precautions: avoid
decongestants
Adverse effects: rebound or deterioration of
behavior when medication wears off;
emotional instability, tearfulness, social
withdrawal, flattened affect, insomnia, poor
appetite, stomach pain, weight loss, reduced
growth velocity, headache

Ritalin-SR

Average:
4.7 hours;
range: 1.3
to 8.2
hours

60 to 90
minutes

5 to 8
hours

Same as above Tablets should not be cut in
half or crushed.

Concerta

NA

1 to 2
hours

12
hours

Same as above

Generic, Dexedrine

1 to 2
hours

20 to 60
minutes

4 to 6
hours

Same as methylphenidate plus avoid
concomitant use with monoamine oxidase
inhibitors

Dexedrine Spansules

NA

60 to 90
minutes

6 to
10
hours

Same as methylphenidate

Amphetaminedextroamphetamine
(Adderall)

1 to 2
hours

30 to 60
minutes

4 to 6
hours

Same as methylphenidate

Pemoline (Cyclert)

Variable
Steady
state in 2
to 3 days
Titrate
dosage
every 3 to
4 weeks

2 hours
(variable)

6 to
10
hours

Informed consent must be obtained before this
drug is prescribed.
Required monitoring: alanine aminotransferase
level at baseline and every 2 weeks; inquire
about anorexia, malaise, gastrointestinal
symptoms, dark urine.
Adverse effects: choreoathetoid movements,
liver dysfunction, liver failure, plus same as
methylphenidate

(Adapted from: Smucker and Hedayat. American Family Physician Vol. 64, No. 5 /
September 1, 2001. www.aafp.org/afp)
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With all of these drug options available for the treatment of ADHD one would
assume that ADHD is a definite disease with a definitive diagnosis; however, this is far
from the case. The diagnosis of ADHD is more complex than first imagined. The exact
definition of this disease, the steps of its diagnosis, and problems with that diagnosis are
the focus of the next chapter.
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CHAPTER III

DIAGNOSING ADHD
DSM IV Guidelines for ADHD
One must ask if ADHD is a medically recognized disorder or illness. While it is
known that Dr. Bradley was studying this subject in the mid-1930’s, it wasn’t until the
early 1970’s that an actual “name” was given to the problem. Before that time, these
children, predominantly boys, were just considered deviant or delinquent. They were
dealt with according to their individual acts and consequences were attached to such acts.
Developments in the understanding of ADHD have lead to firmer definitions.
The American Academy of Pediatrics, and the American Academy of Child and
Adolescent Psychiatry have put together key elements and specific guidelines to follow in
diagnosing ADHD. The following rating scales offer very specific symptoms that
psychiatric professionals have devised to aid in the recognition and ultimate diagnosis of
ADHD to be used by families, educators, family physicians, as well as psychiatric care
professionals who have children with suspected ADHD referred to them. While these
standards are not the only interpretation of ADHD and its symptoms, they are the
recognized guide to a medically valid diagnosis of ADHD and the checklist for parents,
educators, and physicians is also thought to be helpful in the diagnosis of associated
conditions which may reveal that the initial diagnosis of ADHD is masking another
condition with its own symptoms and evaluation procedures.
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Combined AAP and AACAP Practice Guidelines for the Evaluation of ADHD:
Recommendation 1:
In a child 6 to 12 years of age who presents with inattention, hyperactivity, impulsivity,
academic underachievement or behavior problems, the primary care physician should
initiate an evaluation for ADHD. The initial assessment should include the following:
a. Standard history and physical examination, with the AACAP recommending a
review of the child's developmental history, confirmation of normal hearing
and vision, and a review of the family history for ADHD, learning difficulties
or psychiatric illness
b. Neurological examination
c. Family assessment, with the AACAP recommending assessment of family
stressors and family coping style
d. School assessment (see recommendation 4)
Recommendation 2:
The diagnosis of ADHD requires that a child meet diagnostic criteria for the disorder.
(See the Combined AAP and AACAP Practice Guidelines for the Symptoms of ADHD)
Recommendation 3:
The assessment of ADHD requires evidence directly obtained from parents or caregivers
regarding the core symptoms of ADHD in various settings, child's age at onset of the
symptoms, duration of symptoms and degree of functional impairment.
a. Use of (ADHD-specific) scales is a clinical option when evaluating a child for
ADHD.
b. Use of broadband scales is not recommended in the diagnosis of ADHD.
Recommendation 4:
The assessment of ADHD requires evidence obtained directly from the classroom teacher
(or other school professional) regarding the core symptoms of ADHD, duration of
symptoms, degree of functional impairment and coexisting conditions in the child. A
physician should review any reports from a school-based multidisciplinary evaluation,
including assessments from the child's teacher or other school-based professional.
A. Use of (ADHD-specific) scales is a clinical option when evaluating a child for
ADHD.
B. Use of broadband scales is not recommended in the diagnosis of ADHD.
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Recommendation 5:
The evaluation of a child with ADHD should include an assessment for coexisting
conditions (i.e., learning and language disabilities, oppositional defiant disorder, conduct
disorder, anxiety and depression).
Recommendation 6:
Other diagnostic tests are not routinely indicated to establish the diagnosis of ADHD.
(Adapted from the American Academy of Pediatrics Committee on Quality
Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. March 2001:
Prevalence and Assessment of Attention-Deficit/Hyperactivity Disorder in Primary Care
Settings Volume 105, Number 5 May 2000, 1158-1170).

Combined AAP and AACAP Practice Guidelines for the Symptoms of ADHD:
A. Either 1 or 2:
1. Six (or more) of the following symptoms of inattention have persisted for
at least six months to a degree that is maladaptive and inconsistent with
developmental level:
Inattention
a. Often fails to give close attention to details or makes careless
mistakes in schoolwork, work or other activities
b. Often has difficulty sustaining attention in tasks or play activities
c. Often does not seem to listen when spoken to directly
d. Often does not follow through on instructions and fails to finish
schoolwork, chores or duties in the workplace (not due to
oppositional behavior or failure to understand instructions)
e. Often has difficulties organizing tasks and activities
f. Often avoids, dislikes or is reluctant to engage in tasks that require
sustained mental effort (such as schoolwork or homework)
g. Often loses things necessary for tasks or activities (e.g., toys,
school assignments, pencils, books or tools)
h. Is often easily distracted by extraneous stimuli
i. Is often forgetful in daily activities
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2. Six (or more) of the following symptoms of hyperactivity-impulsivity
have persisted for at least six months to a degree that is maladaptive and
inconsistent with developmental level:
Hyperactivity
a. Often fidgets with hands or feet, or squirms in seat
b. Often leaves seat in classroom or in other situations in which
remaining seated is expected
c. Often runs about or climbs excessively in situations in which it is
inappropriate (in adolescents or adults, may be limited to
subjective feelings of restlessness)
d. Often has difficulty playing or engaging in leisure activities quietly
e. Is often "on the go" or acts as if "driven by a motor"
f. Often talks excessively
Impulsivity
g. Often blurts out answers before questions have been completed
h. Often has difficulty awaiting turn
i. Often interrupts or intrudes on others (e.g., butts into conversations
or games)
Other Considerations
a. Some hyperactive-impulsive or inattention symptoms that caused
impairment were present before the age of seven years.
b. Some impairment from the symptoms is present in two or more
settings (e.g., at school [or work] and at home).
c. There must be clear evidence of clinically significant impairment
in social, academic or occupational functioning.
d. The symptoms do not occur exclusively during the course of a
pervasive developmental disorder, schizophrenia or other
psychiatric disorder and are not better accounted for by another
mental disorder (e.g., mood disorder, anxiety disorder, dissociative
disorder or a personality disorder)
(Adapted from the American Academy of Pediatrics Committee on Quality
Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. March 2001:
Prevalence and Assessment of Attention-Deficit/Hyperactivity Disorder in Primary Care
Settings Volume 105, Number 5 May 2000, 1158-1170).
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The family assessment rating scale (See Table 3) can be used by any individual to
assess the common markers for ADHD. However, the assessment of family members
and teachers are subject to variation and there is no standard under which their answers
are judged. Perceptions of the severity of symptoms can be aggravated, not only by
factors unknown to the primary evaluator, but to the familial evaluators own biases.
Despite this drawback, the rating scale remains one of the most often used, but least
explained evaluation tools in the fight against ADHD. While the family assessment scale
is a valuable tool, the combined AAP and AACAP symptom guidelines are a more
precise system, and are generally regarded as standards for use by healthcare providers.
However, evaluation between the healthcare evaluator and familial evaluators using both
the familial rating scale and the healthcare symptoms guidelines might increase the
understanding of both parents and educators. This increased understanding might relieve
some of the anxiety associated with the process, and in turn eliminate even more potential
for misdiagnosis.
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Table 3 ADHD Rating Scale IV
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As was the case with the personal interview conducted for this study, parents are
often confused by the results garnered from all of these forms. No sufficient explanation
was made the parent or informant questioned for this study and the parent expressed selftermed “anxiety” over the amount of figures, numbers, and statistics that healthcare and
education providers offered with little or no explanation. The parent expressed confusion
concerning how it was determined that their child exhibited “medically significant”
behaviors that were “any worse” than other children. The ADHD Rating Scale Scoring
and Norms (Table 4) is an often-underused resource to help parents comprehend how far
their child falls outside the normal percentile ranges. Such information is essential to
fully informed parental consent. Parents may choose alternative therapies, excluding
Ritalin and Ritalin-type drugs; if they feel their child is not significantly deviated from
the norm.
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Table 4 ADHD Scaling Ratings and Norms

(All tables Adapted from: Smucker and Hedayat. American Family Physician Vol. 64,
No. 5 / September 1, 2001. www.aafp.org/afp).
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Adherence to DSM IV Guidelines for Diagnosing ADHD
These standards cannot be taken lightly as up to Nineteen percent of school age
children have behavioral problems with half of that group displaying ADHD symptoms,
(Smucker and Hedayat, 817). The family physician is usually asked to evaluate the child
when he or she is doing poorly in school, has disruptive relationships with peers or
parents, and displays defiance when parents discipline them. Screening for the presence
of a co-morbid condition, i.e. Depression, Conduct Disorder1, Oppositional Defiance
Disorder2, Tourette’s syndrome3, or Sexual Abuse4 is of the utmost importance when a
proper diagnosis is to be made and treatment is expected to be successful. A systematic
approach to diagnosis can help the doctor avoid the tempting and time efficient urge to
forego a comprehensive evaluation and instead write a prescription and recommend a
follow-up which may or may not happen depending on the time constraints of both the
parents and the physician.
Any successful effort to treat a child is a cooperative one. Parents and teachers
also need to be patient when seeking help for these children. The final diagnosis may,
and should require many office visits. Numerous tests are required in the DSM IV
guidelines, to finalize the diagnosis and treatment of the child with suspected ADHD.

1

A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or
rules are violated American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.
Washington, D.C.: American Psychiatric Press, 1994 (651)

2

A pattern of negativistic, hostile, and defiant behavior lasting at least 6 months. American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, D.C.: American Psychiatric Press, 1994 (802)

3

A consistent pattern of non-rhythmic, rapid and recurrent motor or vocal tics is present. American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, D.C.: American Psychiatric Press, 1994 (1170)

4

Any pattern or instance of inappropriate physical contact which may or may not include actual intercourse. American
Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, D.C.: American
Psychiatric Press, 1994 (494)
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Ignored Factors in the Diagnosis of ADHD
Many researchers recommend that these children should all be placed in an
Individualized Treatment Plan (ITP) that addresses not only his or her symptoms of
ADHD, but also co-morbid conditions mentioned above. They then suggest that after a
treatment plan is in place several intervention modalities should be addressed: 1)
Psychosocial, 2) Behavioral, 3) Educational, 4) Pharmacological, if needed.
It would seem the problem with following the DSM IV guidelines is one of
neglect and not an actual problem within the guidelines themselves. It has been my
experience that primary care physicians don’t follow the diagnostic criteria, or the
recommended diagnosis schedule. Instead they move quickly to the fastest and most
immediate fix, drug therapy.
Often children are placed on drugs like Ritalin, Adderall, Risperdal, or Catapress
without a thorough psychiatric follow-up. Factors, which should be taken into account,
are ignored. Several other conditions might make up the core of these children’s
behavioral problems, and they are skimmed over or ignored after the initial diagnosis.
Environmental factors, family dysfunction, learning disabilities, hearing and or vision
problems along with a number of other physiological conditions may be part of the
disorder being diagnosed as ADHD. According to Dr. Peter Breggin, several
psychological problems can produce ADHD-like symptoms, including: autistic disorder,
major depressive disorder, generalized anxiety disorder, post traumatic stress disorder,
avoidant personality disorder, separation anxiety disorder, and social phobias (Talking
Back to Ritalin, 211).

Up to nineteen percent of school age children have behavioral problems,
with half of that group displaying ADHD symptoms. The family
physician is usually asked to evaluate the child when he or she is doing
poorly in school, has disruptive relationships with peers or parents, and
displays defiance when parents discipline them” (Smucker and Hedayat,
817).
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Often these problems are first noted or expressed in the classroom and it is there
that the diagnostic process begins. Educators urge parents to seek help for their child,
and naturally a parent’s first contact is the family pediatrician. At this level drug therapy
may be started, prior to the actual testing needed to adequately diagnose ADHD. This
practice while expedient can be damaging to the child and directly violates the
recommendations of many psychiatric care professionals and the DSM IV guidelines.
Once the diagnosis is made and a treatment is agreed upon parents, educators and
children themselves are then left with a myriad of new issues to discuss, consider, and
ultimately make choices about for the child. Coping with the diagnosis and coming to
terms with medications and treatment are the focus of the next chapter.
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CHAPTER IV

BEYOND DIAGNOSIS
Understanding the Terminology
In studying the widespread use of stimulants to treat ADHD, substantial
controversy has been generated. The media is very involved on both sides of the debate,
and one area of interest is the long-term safety and efficacy of the use of these drugs. For
example, The National Institute of Mental Health sponsored a study on this subject and
found that chronic use of these stimulants may increase the risk for substance use and
abuse later in life.
Although at least one study found the opposite to be true (Biederman, et al, 1999,
63). Ultimately the issue of the use of stimulants had significant long-term effects, either
positive or negative, is as of yet undetermined.
Another controversial issue pertaining to the use of stimulants (and the other
classes of drugs discussed here) is the growing frequency with which these are prescribed
for behavioral problems in children and adolescents. One study documented the
increased use of psychotropic medications in children, especially those younger than six
years of age (Zito et al, 2000, 1027). The study reported a 1.7-3.1 fold increase in the use
of medication (most of ten Ritalin) for the treatment of behavioral problems in preschool
children.
All of this medication leads to several confusing questions. A basic
understanding of these drugs must be taught to the parents and teachers involved in the
care of a child diagnosed with ADHD. Psychopharmacology is the study of the
psychological and behavioral effects of drugs. Teachers and parents who are
knowledgeable about the principles of psychopharmacology will be able to better
understand the manner in which medications alleviate behavior problems in children with
ADHD. Four basic concepts to consider are: 1) clinical effects vs. side effects, 2) dose
response, 3) half life, and 4) peak effect, (Kollins et al. 4).
The clinical effect refers to the reduction of symptoms noted. Behavioral and
emotional problems that are causing difficulty in the child’s life will be alleviated
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through manipulation of neurotransmitters in the brain such as dopamine and
norepinephrine, (Wilens 1999, 107). These neurotransmitters, however, also are
associated with elevated arousal elsewhere in the central nervous system. Consequently,
in addition to the expected clinical effects of improved concentration and attention, these
drugs may increase blood pressure, heart rate, increase respiration, decrease or increase
appetite, and disrupt sleep patterns in some children. It is an important part of the
management of any behavioral or psychological problem through the use of stimulants to
balance the clinical effects of the medication with the potential side effects. One way to
monitor this process is through the careful check and recording of vital signs and
physiological reactions. Yet, I think it would be safe to say that many of these children
do not receive any such monitoring at school and may not receive any of it at home.
Without monitoring side effects could mushroom into greater problems that might have
been avoided with proper care and monitoring.
Dose response simply refers to what dose is given to achieve a desired behavior or
emotional response in the child.
Guidelines are as follows:
1) Behavioral improvement is related to step by step increase in dose.
2) Behavioral improvement is subject to a threshold effect at a moderate or high
does
3) Behavioral improvement reaches a peak at a moderate dose and shows a
decrease at higher doses; or
4) Behavioral improvement is inconsistent across doses,
(Rapport et al. 1986, 339).
Parents, physicians, and educators must also take note that “the manner in which
dose influence(s) various areas of functioning (academic, social, emotional) varies
considerably, both across children and even within the same child” (Douglas et al.,
1995,397; Sprague and Sleator 1977, 1275; Tannock et al, 1989, 651).
Half-life is related to the effect of the drug on the body over time. Because, as
stated above, the effects of a drug are related to the amount of the drug in the body, it
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follows that the faster the drug is broken down and eliminated from the body, the shorter
is the amount of time the drug will exert its effects.
The final basic principle of psychopharmacology that is important for parents and
educators to understand is that drugs (especially stimulants) often exert their optimal
clinical effects at a certain point after administration. This point is called the peak effect,
and varies with each drug. This means that although beneficial effects may be observed
sooner, the maximum effect of the drug is not likely to occur until well after the dosage is
taken and that the effect after that optimal time will begin to diminish, (Birmaher et al,
1989, 769 and Pelham et al, 1987, 493)
Once parents and educators of children with ADHD establish understanding of
psychopharmacology and knowledge of the kinds of drugs typically used to treat ADHD,
they should be made aware of well-established procedures for effectively evaluating the
efficacy of those medications.
It is my understanding that a majority of parents and educators are not adequately
informed about the way in which stimulants function in the body, and the importance of
consistent monitoring of the child’s physiological response and the possible adjustment,
rather than increase, of dosages. This knowledge is vital and necessary as the behavioral,
emotional, and physical health of these children may depend on such diligent care.
Questions, which should be asked and more importantly are not, are: Are all parties of
responsibility (doctor, parent, and educator) evaluating the need of and administering
these drugs properly? Are educators specifically aware of the changes in behavior a child
will experience when the half-life or peak effect of any stimulant is reached? Is enough
being done to ensure that these children’s vital signs and overall health are kept within
normal limits while they function in and outside the classroom?
If the death of Michigan native Matthew Smith, on March 21st 2000 is any
indication, then not all children are being monitored effectively for the effects the drugs
might have on them in general and how it might interact with any preexisting conditions.
According to a CNN edition of the World Today, which aired on April 17, 2000 - 8:29
p.m. EST, Dr. L. J. Dragovic, medical examiner, Oakland CO., Michigan, the physician
who autopsied the fourteen-year-old boy attributed his death to the constriction of blood
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vessels that supply the heart caused by the chronic use of Ritalin. There are those who
say Smith’s death could not have been caused by Ritalin and he therefore must have had
some preexisting heart condition, but no such condition was ever diagnosed before his
death and the autopsy showed no signs of damage that was not attributed to chronic
stimulant use. This sort of monitoring was not in place for Smith. Many physicians say
that such monitoring is not necessary; however, according the Canadian Paediatric
Society,
The physician must be available to the parents to monitor the drug effects
and to regulate the dosage. The decision to provide "drug holidays" on
weekends or during the summer must be decided on an individual basis
depending on the child's need for improved attention control and
behaviour at these times. Since side effects are rare, there is no logical
reason to deprive children and parents of the benefits to self-esteem and
family dynamics obtained through daily administration if required.
Effective drug therapy should be continued so long as there is clear
benefit; a trial without medication, preferably blind to familiar observers,
should be performed at least annually. Serial measurements of height,
weight and blood pressure are mandatory (818).
In short, monitoring is necessary; panic is not. It is this balanced perspective on
the harm of Ritalin and Ritalin-type drugs which is missing from the North American
discourse on drug therapy and children. Although once one assesses the possible side
effects of these stimulants it is easy to see how panic becomes an option, and for some
the only option in such discourse.

Physiological Effects of Medication Used to Treat ADHD
Dr. Peter R. Breggin is an outspoken critic of the use of amphetamines to treat
children. He notes that, “Ritalin and amphetamines such as Adderall have almost
identical adverse effects on the brain, mind and behavior, including the production of
drug-induced behavior disorders, psychosis, mania, drug abuse, and addiction” (2001,
335). He also writes that the drugs often cause the same conditions they are prescribed to
treat like hyperactivity and impulsivity. The drug might also have the reverse effect and
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cause a child to become lethargic, withdrawn, depressed, or robotic. Furthermore the use
of Ritalin has been linked to the development of permanent neurological disorders like
Tourette’s syndrome. They have also been linked to the retardation of growth, growth
cycles regulated by the pituitary.
Dr. Breggin writes,
Ritalin and amphetamines like Adderall routinely cause gross
malfunctions in the brain of the child. There is evidence from controlled
scientific studies that Ritalin can cause shrinkage (atrophy) or other
permanent physical abnormalities in the brain. Amphetamines, including
Adderall and Dexedrine, cause cell death in animals in relatively low
doses (2001, 335).
While these facts may be shocking there are families in need of help, and some of
them may feel they can only get that help from medication. If the offered stimulants are
not an option, or the option comes at too high a cost for the family, where they can turn is
of primary importance.

ADHD and Alternative Therapies
When drugs are not the answer several other options still exist. EEG Biofeedback
therapy, diet modification, herbal supplements, acupuncture, and straightforward
behavior modification therapy are all choices available to varying degrees depending on
which area of the country one lives in. According to EEG Spectrum International,
“Human EEG biofeedback was first attempted in the 1960s by Joe Kamiya at the
University of Chicago. Early investigations focused on operant conditioning of alpha
brain waves primarily to facilitate deep relaxation and meditation” (EEG Spectrum
International http://www.eegspectrum.com/HealthProfFAQ/Faq). This form of treatment
does however require the use of electrodes and may therefore be undesirable to some
parents. Acupuncture falls under the same sort of prohibition as many children express a
fear of needles, which might unduly agitate them. As herbal supplements are not
regulated by the FDA, this solution may be considered undesirable as well. Dietary
changes on the other hand are a cost-effective, somewhat safe way to attempt to control
ADHD. According to Dr. Breggin, there is growing evidence in controlled, double blind
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studies that the removal of food products that produce allergies like peanuts, as well as
products including: monosodium glutamate, caffeine, preservatives, dyes, and other
additives from the diet has produced a reduction in ADHD symptoms (2001, 211).
This sort of therapy may not be enough on its own, but this therapy in concert
with traditional behavior modification therapy by a qualified professional, in addition to
the cooperation of educators and school counselors may be, for many families, a path to
negotiating their children through school without the addition of drugs.
Dr. Breggin cautions that these alternative therapies reinforce the idea that the
problem is a physical or mental one, and may mask a real physical condition, which is
producing ADHD-like symptoms. He recommends instead the incorporation of
treatments, which enhance self-discipline and autonomy for the child and strengthen the
family structure (2001, 214). It is this family structure, which is the focus of the
following chapter.
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CHAPTER V
ADHD AND THE FAMILY
Divorce and ADHD.
Dr. Martin Stein MD, Professor of Pediatrics at the University of California, San
Diego School of Medicine, sites two high-prevalence conditions that have significant
effects on the development of children: divorce and ADHD. The United States has the
highest divorce rate of any developed country, with half of all marriages ending in
divorce. That statistic translates to approximately one million children annually who are
the emotional victims of divorce. With the combination of single-parent homes and
divorce, approximately 60% of all American children at some time live in single-parent
families (2001, 867).
It is my belief that an environment created by a high-conflict divorced family with
arguments, screaming, physical threats, physical violence, monetary pressure, court dates,
and/or general parental instability could lead to the symptoms of ADHD in the children
of these families. Another diagnosis such as acute stress reaction or adjustment disorder
may more appropriately define the nature of the symptoms displayed. Such symptoms
could theoretically continue for years if the family chaos is not contained and equilibrium
is not established. Without stabilization a repetitive set of behaviors might easily become
the norm for a child, and the cause could be simple dysfunction rather than ADHD.
Often in conjunction with the chaos and family dynamics between the divorcing
parents come disagreements related to the actual diagnosis and necessary treatment for
the child. This would place the child in an uncomfortable situation where the child learns
to act differently with each parent. This sort of behavior would lead to completely
different reporting to a health care professional from each parent. This sort of activity
can only, and often does confuse the issue and the diagnosis and treatment.
Practice guidelines for ADHD stress the need for multiple informants, and these
informants must be accurate in their assessment of the child’s symptoms. Often times,
the divorcing parents will fight each other over these symptoms, blaming the other for the
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child’s problems. These conflicts only add to the problem, and exaggerate the symptoms
displayed.
It is very important that both parents contribute to the overall treatment plan, or in
the absence of two parents then some extended family contribute. Decreasing tensions
between parents, or decreasing stress for the one parent may decrease the negative
behaviors engaged in by the child after a divorce or separation. The need for medication
and intervention may be eliminated.
Another problem that often occurs after divorce is what some have called Dad
Attention Deficit Disorder (DADD). This condition refers to the separation of children
from the emotional and physical presence of their father who often no longer lives with
them (Breggin and Breggin 1995, 59).
According to others the cure for these children is more rational and loving
attention from their parents. It is theorized that young people today, especially young
men (those most often diagnosed) are hungry for the attention of a male figure. It is
further theorized that impulsive and hostile behaviors might calm down when a caring,
relaxed, and firm adult male is a presence in the life of the child (Smith 1993, 5).
It is almost inevitable in American society that even if both parents are in the
home, they both most often also work outside the home. This pattern limits the amount
of time a parent has to spend with a child and if this alone does not create a behavior
disorder, it contributes to the need for expedient treatment, and that treatment is most
often one that involves medication(s).

Paul Johnston: The Escalation of Medication
The long-term effects of Ritalin and Ritalin-type stimulants are not yet known as
the first generation of “Ritalin-children” are just now entering adulthood. What we do
know is that these drugs produce some significant side effects that can cause more harm
than good to the emotional, physical, and behavioral health of a child. One child, whose
experience with Ritalin was damaging, is Paul Johnston (See Appendix A), a thirteenyear-old boy from West Virginia. His story was featured in the July 23, 2001 edition of
People magazine and Johnston’s is a true horror story.
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When Johnston entered kindergarten his doctors diagnosed him with ADHD and
prescribed Ritalin at the age of 5. This drug failed to quiet his ADHD. His mother notes,
“He was moody. He would not sleep. He would not eat” (Rogers, July 2001, 55). His
behavior then began to deteriorate at home and he was disruptive and destructive. This
behavior continued and the Johnston’s took him to at least 14 separate doctors. Other
stimulants, antidepressants and anti-psychotics were then prescribed in varying degrees.
They also seemed to fail.
Johnston began hearing voices in 1997 and was placed on Risperdal to control
this psychotic manifestation in his behavior. Risperdal is known to cause permanent
damage to the body including recurrent tics and other problems. This did not help either.
On September 19, 1997 Paul Johnston took a knife to his own chest and cut gashes in it.
Episodes like this forced Paul into treatment at psychiatric facilities on four occasions
before he was finally committed for an extended stay in 2000.
Paul Johnston’s regime of medication escalated from one dose of one drug to
more than five prescriptions at once for what was originally diagnosed as ADHD.
Johnston was eventually weaned from all the medications in his system and his parents
were encouraged to provide better discipline in the home to combat his behavior. This
treatment plan, while imperfect, is still preferable to his parents then slashing his chest
(July 2001, 50-55).
Two points illustrated by Johnston’s story are open to further consideration. The
article notes that Paul’s behavior once made him an outcast in his community. ADHD’s
association to the concept of self is incredibly important to the overall picture of this
disorder. The other consideration is one of educational pressures on children and parents
to medicate for ADHD. The latter of these will be covered in a later chapter.
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ADHD and the Self
How does ADHD affect a child’s self-image? This is a question not often asked.
Paul Johnston was considered a social pariah in his neighborhood not only because of his
bad behavior, but also because of the associated ideas related to the vast list of
medications he received. How does medicalization behavior affect the child in the
outside world? Some would say it is damaging. Does Ritalin undermine a child’s ability
to control its own behavior? Some say yes. Stoufe and Stewart wrote as early as 1973,
The child can conclude that he is not responsible for his
behavior: “I can’t help being bad today. I haven’t had my
pill.” The child comes to believe not in the soundness of
his own brain and body, not in his growing ability to learn
and to control his behavior, but in “my magic pills that
make me into a good boy and make everybody like me
(Stoufe and Stewart 1973 as cited in Breggin 2001, 412)

Dr. Breggin’s current observations offer no better interpretation of a child’s reaction to
being medicated. In Talking Back to Ritalin he writes,
As in the Walter Reed study, being diagnosed and
medicated seemed to undermine many children’s sense of
being in charge of themselves, their actions, or their lives.
One child said, “I think it is a kind of sickness, because it, it
kind of takes over, I know it takes over my body…it’s like
you don’t have that much control…I kind of feel weird,
because you need a pill to control yourself, (2001, 234).
In the interview the informant mentioned feeling distinct discomfort with taking
Ritalin while in school, and expressed particular distress at being one of three boys who
were forced to sit near the door of their classroom so that they might not disrupt the
others when they went to get their pills. This child was publicly isolated, segregated, and
made to feel defective and inferior in an attempt to control a behavior disorder, which not
all medical professionals can even agree exists (Anonymous, Personal Interview March
1, 2002).
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The informant indicated more than once a dislike for the medication, and
indicated that several other medicated children in the child’s school felt the same way
(Anonymous Personal Interview March 1, 2002). This sort of inference is confirmed by
the high rate of noncompliance-failure or refusal to take the medication. Non-compliance
varies from ten to thirty percent in closely monitored research projects in clinical
practices. These statistics are over a decade old and are probably higher today with the
increase in use of stimulants to treat ADHD in the United States. The feelings of children
in reaction to Ritalin were studied in a project funded by the Institute of Child Behavior
and Development at the University of Illinois. The results were seldom cited in
ADHD/Ritalin reviews until they appeared in Dr. Breggin’s book Talking Back to
Ritalin. Among the children diagnosed with ADHD, many hated the drug, and how it
made them feel, but lied to their doctors about it. The researchers found inconsistencies
in interviews, by observing behavior outside the sessions, and by questioning adults about
the children’s willingness to take the drug. The study concluded that a pervasive dislike
existed among hyperactive children for taking stimulants. Forty-two percent disliked or
hated taking the drug. Sixteen of the children in the study reported embarrassment about
being on Ritalin. The researchers concluded that the children’s statements only reflected
what they thought their parents or their doctors wanted to hear. The study ultimately
found the physicians at fault because as trained medical professionals they should have
been able to detect a dishonest response from their patients. The study also raised the
possibility that a great many patients who were thought to be improving, were not even
taking their medication (Breggin 2001, 271-273).
Jensen found that taking Ritalin produced the following negative psychological,
moral, and social effects:
1) “Defective super-ego formation” manifested by “disowning
responsibility for their provocative behavior”
2) “Impaired self-esteem development”
3) “Lack of resolution to critical family events which proceed the
emergence of the child’s hyperactivity”
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5) Displacement of “family difficulties” onto the child (2001,
135).

These children believe they are bad and they believe the medication is given to
control that badness. Kate Clarke, a social worker in the Illinois public school system,
researching for her unpublished doctoral dissertation, studied the feelings children have
related to being diagnosed with ADHD and being treated with Ritalin.
Medically the children reported adverse drug effects consistent with most studies,
impact on the child’s sense of self was of larger concern. Many children expressed the
idea that they thought people believed they were stupid, weird, or sick. Teasing and
ridicule are common in the life of a child on Ritalin. Often these children will hide the
fact that they are on medication (Clark as quoted in Diller 1996, 17).
Educator Michael Valentine emphasizes that our belief system about a child will
affect our expectations and communication with a child. He believes than the ADHD
diagnosis limits our expectations and encourages children to give up self-control (23).
How does the child reconcile this forced image of an illness, handicap, or
disorder? Few are asking them, and few are helping them. One wonders how a child
copes with the idea that their brain, where they are often told the “stuff” is that makes
them who they are, is beyond their immediate control and must be controlled by some
external force. This action seems, in my opinion, counterproductive to the entire concept
of modifying behavior, and may do more harm than any good the medication may do.
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CHAPTER VI
ADHD AND SOCIETY
The Pressure of Educators
On September 29, 2000, Dr. Breggin testified before the U. S. House of
Representative’s sub-committee on Oversight and Investigation Committee on Education
and the Workforce. Dr. Breggin’s argument began with the assertion that parents
throughout the country were being pressured and coerced by schools to give psychiatric
drugs to their children. Teachers were described as threatening and demanding. They
expressed the belief that these children were not teachable unless they were medicated.
They further suggested that only medication could stave off a bleak future of delinquency
and occupational failure. Child protective agencies were at times called in, and parents
were charged with neglect if they refused to medicate their child (Breggin 2001, 298).
He further asserted that particular physicians were being used because they were
known to favor stimulant therapy for the over-active child. Paul Johnston’s family also
felt pressure from their school system to medicate their child (July 2001, 55), and my
own informant’s parents felt equally pressured by the school system and the family court
system to medicate their child (Anonymous Personal Interview, March 1 2002).
This sort of pressure has to stop. Educators, while valuable members of a
community, are not medical professionals and while their extended contact with a child
may allow them insights others often miss, this in no way should give them the right to
dictate to parents the appropriate course of action concerning a child’s mental health.
Rather their services would be better used filling out the questionnaires provided to
diagnosis ADHD so that more definitive diagnosis might be made.

The Pressure of Advertisements
What is behind the drastic increase of psycho-pharmaceutical drug usage in the
United States? Why is the general public not informed about the full scope of Ritalin?
Why have no long-term studies been done concerning the aftereffects of years of Ritalin
and Ritalin type drugs?
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The answers lie in the politics of the American Psychiatric Association and their
“partnership” with pharmaceutical companies. In the 1970’s the APA was all but broke.
Competition from non-medical professionals was cutting into the income of private
practices. Psychologists, social workers, counselors, and family therapists were taking
over the field. With smaller fees and better access to help, patients were seeking help
from these professionals in record numbers.
At this point psychiatry had to convince the American public that psychological
illness should remain under the control of psychiatrists. One way to do this was to
generate the idea that these illnesses are genetically and biologically determined;
therefore medical intervention is required.
A major step taken was the revision of the Diagnostic and Statistical Manuel of
Mental Disorders. In these revisions, disorders became “medical” illness thus ADHD as
an illness was born. By elaborating on ADHD as “disorder” stimulant intervention
became more and more justifiable.
The problem with this plan came from the actual cost of revising the manual. The
association was in deep debt and such a move would have been impossible without an
influx of outside money.
Pharmaceutical companies from around the world were ready with that money. In
the early 1980’s the APA formed partnerships with these companies and forever changed
society, as we knew it. The political and economic partnership would enable the APA to
receive funds from drug companies to promote the medical models they needed to
financially survive. Backed by a multi-billion dollar industry, psychiatry would not only
survive, it would flourish and grow into a financial giant in its own right. The APA soon
had lobbying groups in state capitals and in Washington D.C., growing stronger as an
influence on the media as well as the courts.
This plan to save the APA was never a deal done under the table. It was openly
discussed, carried out, and reviewed in Dr. Breggin’s Toxic Psychiatry. Ethical issues
were immediately raised within the APA related to this financial dependency on drug
companies; however, arguments soon were quieted when money began to flow. The
APA soon bragged in its newsletters about revenues being made through this partnership.
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Drug companies were now funding research projects and paying for fellowships at the
APA. Local and national conventions were totally funded by drug companies (1991,
339).
Drug companies now fund the largest percentage of research. Research centers
across America were and are dependent on these companies. Lack of cooperation
prevents important, even vital research from taking place or being shared.
Needless to say Ritalin research is directly compromised by these partnerships. To
date there are no long-term studies on the effects of Ritalin on induced atrophy of brain
tissue, or on the irreversible damage of long-term stimulant use (Breggin 2001, 349-356).
Can any logical parent doubt the conflict of interest in a financial partnership between
drug companies and the APA? Dr. Lester Shapiro used the term collusion to describe his
findings on the subject. Dr. Shapiro states, “The APA colludes with drug companies
whose interest lie in broadening the marketing, encouraging long-term use, minimizing
the dangers of drugs, and belittling alternatives to drugs” (1991, 241).
The Psycho-pharmaceutical Complex is a very close association; a partnership to
some and collusion according to others. This complex brings together drug companies,
researchers, doctors, government agencies, and various medical organizations including
the APA, medical schools, and insurance providers. All these groups benefit from the
ever-growing use of psychiatric drugs in the United States.

Dr. Breggin cites six major players in the Psycho-pharmaceutical Complex:
1) The American Psychiatric Association (APA)
2) Ciba Geneva Pharmaceuticals; a division of Novartis (the makers of
Ritalin)
3) CHADD (Children and adults with Attention Deficit Disorder) an
influential organization that receives money from Novartis
4) The U. S. Department of Education (DOE)
5) The National Institutes of Mental Health
6) The Food and Drug Administration (FDA)
(Breggin 2001, 293).
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Drugs to treat ADHD have become a significant subject in the minds of parents
all over the world. From trycyclic antidepressants to stimulants and anti-hypertensives,
the use of drug therapy on children with questionable behavior has become, to say the
very least, big business.
In the early days of this treatment, pharmaceutical companies, without legal
pressure, agreed not to advertise narcotics that would assist in calming American
children. However, very recent advertisements in popular magazines have begun this
practice. In September 2001, a variety of woman’s and parenting magazines saw the first
advertisements promoting narcotic therapy for children with ADHD. (See Appendix: B,
C, and D).
While the anti-hypertensives and antidepressants are not considered schedule II,
controlled substances, or narcotics, the amphetamines, (Ritalin, Concerta and Adderall)
are. Advertising these drugs has never been illegal; however, the drug companies, in
good faith never found it necessary to do so. Those days are over due to the huge surge
in the use of these drugs for ADHD, and other behavioral disorders in children and
adults.
The facts presented in the September 10, 2001 edition of Time magazine are
alarming. According to Time, in the past five years alone, sales of prescriptions to treat
ADHD have gone up some thirty-eight percent, In light of what appears to be an
epidemic of ADHD in the United States alone, some 3 million U.S. children are believed
to have this or a related behavior disorder. Furthermore, pharmaceutical companies are
listing, at present, a one billion dollar a year profit from ADHD drugs, and in 1999 a
staggering 20 million prescriptions were written (Novak, 62). With the numbers on the
rise, drug companies are fast at work developing second-generation drugs that last these
kids throughout a school day. These drugs are supposed to lower or remove the stigma
they carry waiting in line at the nurse’s office for their mid-day doses of Ritalin and
similar drugs, and some second-generation drugs already exist and are available for
prescription (See Appendix D).
Companies that advertise these drugs believe that they are doing the consumer a
great service. They state knowledge and options assist in treatment; however, many
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physicians see such advertisements as a double-edged sword, because they drive up the
demand for the drugs. This can be very controversial because these drugs are categorized
by the DEA in the same class as other narcotics like morphine, cocaine, and Demerol.
As alarming as all this sounds, the government’s hands are tied. At the United
Nations convention of 1971, signatory nations agreed to prohibit the advertisement of
psychotropic substances to the public. The United States never passed such a law
(Novak, 62). At this point the nation can only rely on the good judgment of each
company to market with discretion. At present Celltech’s advertisement for Metadate
CD is the only one that names the drug, instead of relying on an 800 number for further
information (see Appendix D). Some advocate groups for persons with ADHD support
these companies, arguing that these advertisements promote public awareness of the
disorder. Others contend that all it does is promote sales.
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CHAPTER VII

CONCEPTS OF DISEASE
Summary and Conclusion
ADHD began with the medication and not the illness. The discovery of the disease
was mere happenstance and subordinate to the discovery that amphetamines could reduce
behaviors that were not considered symptomatic to any defined disease. This state of
affairs was not to remain and the development of new drugs to treat the “disease” ADHD
grew exponentially. The categories of drugs now used to treat the disease includes not only
amphetamines but other classes of drugs which were also not specifically developed to
fight the disease, but rather were discovered to have some effect upon patients.
Determining which individuals should be considered patients is also problematic to ADHD.
The DSM IV guidelines are clear in their definition of ADHD, but it must be considered
that the characteristics, symptoms, and treatment for this “disease” are voted on by
committee, and while the votes are backed up by researcher, no standards for such research
are available for evaluation by concerned parties. Furthermore the DSMIV guidelines are
often not utilized at all and when used are only used partially, or incorrectly. Even when
utilized the results are often to adequately explained to parents or patients, and comorbid
conditions are often ignored all together. The presence of other mental conditions, family
problems, and physical conditions can all contribute to the misdiagnosis of ADHD. If
these factors are ignored children are at the risk of being unnecessarily medicated with
amphetamines.
Even when Amphetamines are properly prescribed, problems occur in the
administering of the drugs. Parents and educators are unfamiliar with the additional
medical conditions and terminology associated with the administrations of medications in
general, and are specifically not prepared for the changing conditions the drug undergoes in
the body, the physiological effects on the patient, or the necessity of monitoring.
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For parents who resist drug therapy, there are alternative therapies available, but
other than some success with food allergies and diet modification to exclude preservatives
dyes and other additives, there are few proven therapies available.
Drug therapies alone are also not always the most complete answers. Family contact, the
effects of divorce, and other socially motivated problems in addition to ADHD are often
ignored and any complete “cure” should include family and individual therapy in extreme
or drug resistant cases. Also behavior modification and family therapy may be the answer
for parents who are resistant to drug therapy. Families may also wish to consider the
addition of therapy to help children cope with the very concept of needing medication.
Research indicates that children may have trouble adjusting to society’s treatment of
medicated or “ill” people, and little or no research is being done on ADHD’s affects on a
child’s self-image and self-esteem. Often parents do not fully consider any of these factors
in whole, and instead opt for the “quick fix” of medication. They are sometimes under
direct pressure from educators, healthcare providers, and the media to seek medication for a
problem, which may only be situational, rather than an inherent disorder within the child’s
brain. That is not to say that the administering of amphetamines to some patients is not a
proven and beneficial therapy, but rather that it is prescribed too often and not seen as the
last resort it should be. Parents and educators need to be made absolutely aware that
Ritalin and Ritalin-type drugs are amphetamines, which can be abused, badly administered,
and in some patients have disastrous effects.
Ultimately a social climate exists which promotes the administering of
amphetamines to children without a proper diagnosis and often with no other monitoring.
Parents and educators who are unwilling to deal with a child’s behavior may find it even
harder to deal with medicated children and associated medical conditions. More drugs are
not the best answer or the only answer for many patients, and the promotion of the “quick
fix” must come to an end. Any mental condition needs corrective measures beyond drugs,
and in no case should drugs be considered the remedy to a child’s fight with ADHD.
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APPENDICES

APPENDIX A:

Johnson pictured here with the medications he was taking, at one time 10 pills per day.
Figure 1 (Photo Credit: April Saul, People Magazine, July 23, 2001)
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APPENDIX B:

Figure 2 (McNeil Advertisement, Ladies Home Journal. Jan, 2002, 34)
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APPENDIX C:

Figure 3 (Shire US Inc. Advertisement Ladies Home Journal Jan 2002 17)
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APPENDIX D:

Figure 4 (Celltech Advertisement. Ladies Home Journal Jan 2002 117)
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CURRICULUM VITAE

With a lifelong interest in helping children, I entered Marshall University in 1977 in
pursuit of a degree in education. As my interests changed and my fascination with
medicine grew, I abandoned my plans for that degree and in 1984 enrolled in the St.
Mary’s School of Nursing where I received a diploma in 1987. Since that time I have
worked all over the country in various hospitals and health organizations as a registered
nurse, either in surgical units, or as part of direct patient care. In 1995 I returned to
Marshall University and received an RBA. The last 2 and one half years I have been
working as an adolescent/child psychiatric nurse while pursuing my MA in sociology from
the same institution. It is this work in adolescent/child care which led to my thesis work on
the use of Ritalin and other narcotics to combat behavioral disorders in children,
specifically ADHD.
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